Adverse impact of a history of violence for women with breast, cervical, endometrial, or ovarian cancer

被引:47
|
作者
Modesitt, Susan C.
Gambrell, Alisa C.
Cottrill, Hope M.
Hays, Lon R.
Walker, Robert
Shelton, Brent J.
Jordan, Carol E.
Ferguson, James E., II
机构
[1] Univ Kentucky, Chandler Med Ctr, Div Gynecol Oncol,Lucille P Markey Canc Ctr, Dept Obstet & Gynecol,Ctr Drug & Alcohol Res,Kent, Lexington, KY 40536 USA
[2] Univ Kentucky, Ctr Res Violence Against Women, Lexington, KY 40536 USA
来源
OBSTETRICS AND GYNECOLOGY | 2006年 / 107卷 / 06期
关键词
D O I
10.1097/01.AOG.0000217694.18062.91
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The experience of physical and sexual violence (victimization) is common among U.S. women and is associated with adverse health consequences. The study objectives were to estimate the prevalence of victimization in women with cancer and to examine associations with demographics, cancer screening, and cancer stage. METHODS: From 2004 to 2005, 101 women with breast, cervical, endometrial, or ovarian cancer were interviewed to collect demographics, cancer screening history, health care access/use, and violence history. Chi-square and Fisher exact tests were used test risk-factor associations. A multinomial logistic regression model was used for multivariable analysis. RESULTS: The prevalence of a history of violence was 48.5% (49/101 women), and within that group, 46.9% (23/49) had a positive childhood violence screen, 75.5% (37/49) had a positive adult screen, and 55% (27/49) reported sexual violence at any age. Women with a positive violence screen differed significantly from women with a negative screen in that they were younger (P = .031), more often divorced (P = .012), more likely to smoke (P = .010), more often lacked commercial insurance (P = .036), and had more advanced stage of disease (P = .013), but they did not differ with regard to race, cancer type, education level, alcohol or drug use, or cancer screening compliance. Multivariable analysis revealed that only stage remained significant; women with a history of violence had a 2.6-fold increased chance of diagnosis in later stages (odds ratio 2.61, 95% confidence interval 1.03-6.59). CONCLUSION: A history of violence in breast, ovarian, endometrial, and ovarian cancer patients was extremely common and correlated with advanced stage at diagnosis.
引用
收藏
页码:1330 / 1336
页数:7
相关论文
共 50 条
  • [1] Impact of ovarian preservation in women with endometrial cancer
    Lau, Hei-Yu
    Twu, Nae-Fang
    Yen, Ming-Shyen
    Tsai, Hsiao-Wen
    Wang, Peng-Hui
    Chuang, Chi-Mou
    Wu, Hua-Hsi
    Chao, Kuan-Chong
    Chen, Yi-Jen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2014, 77 (07) : 379 - 384
  • [2] FAMILY HISTORY OF BREAST, OVARIAN AND ENDOMETRIAL CANCER AND RISK OF BREAST-CANCER
    PARAZZINI, F
    LAVECCHIA, C
    NEGRI, E
    FRANCESCHI, S
    TOZZI, L
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1993, 22 (04) : 614 - 618
  • [3] Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer
    Mogren, I
    Stenlund, H
    Högberg, U
    ACTA ONCOLOGICA, 2001, 40 (07) : 849 - 854
  • [4] Ovarian, cervical and endometrial cancer
    Rousseau, C.
    Salaun, P. Y.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2019, 43 (01): : 104 - 124
  • [5] Ovarian cancer screening in women with a family history of breast or ovarian cancer
    Lacey, James V., Jr.
    Greene, Mark H.
    Buys, Saundra S.
    Reding, Douglas
    Riley, Thomas L.
    Berg, Christine D.
    Fagerstrom, Richard M.
    Hartge, Patricia
    OBSTETRICS AND GYNECOLOGY, 2006, 108 (05): : 1176 - 1184
  • [6] Disparities in Oncofertility: Assisted reproductive technology utilization and fertility-sparing oncology care in women with a history of breast, ovarian, cervical or endometrial cancer
    Jorgensen, Kirsten
    Melamed, Alexander
    Nitecki, Roni
    Fu, Shuangshuang
    Meyer, Larissa
    Smith, Benjamin
    Ramirez, Pedro
    Rauh-Hain, Jose
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S63 - S63
  • [7] Psychosocial impact of the first consultation in oncogenetics on women with a familial history of breast and ovarian cancer
    Blandy, C
    Schwab, S
    Stoppa-Lyonnet, D
    Dazord, A
    BULLETIN DU CANCER, 1998, 85 (07) : 637 - 643
  • [8] The impact of chemotherapy on sleep quality in women undergoing cytotoxic treatment for breast, ovarian, and endometrial cancer.
    Cantillo, Evelyn
    Beffa, Lindsay
    Luis, Christine
    Raker, Christina
    Robison, Katina
    Sikov, William M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Reduced risk of breast, endometrial and ovarian cancer in women with celiac disease
    Ludvigsson, Jonas F.
    West, Joe
    Ekbom, Anders
    Stephansson, Olof
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (03) : E244 - E250
  • [10] Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer
    Isaacs, C
    Peshkin, BN
    Schwartz, M
    DeMarco, TA
    Main, D
    Lerman, C
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 71 (02) : 103 - 112